Recent Headlines
University of Waterloo’s Kimia Lab and Huron Digital Pathology to Participate in $126M Industry Consortium Led by Sunnybrook Research Institute
The Canadian government, through its Strategic Innovation Fund, will invest up to $49 million to support the initiative, which, in addition to Kimia Lab and Huron Digital Pathology, consists of more than 70 partners from industry, academia, government organizations and not-for-profits. The consortium’s mandate is to accelerate the application of artificial intelligence and machine learning technologies to deliver better health outcomes, faster diagnoses and safer treatments. - June 03, 2019 - Kimia Lab, University of Waterloo
Plant-Based Weight Loss Pill Calocurb Rapidly Expands Globally
The ground-breaking plant-based dietary supplement calocurb™ is rapidly expanding internationally. Last week Iceland joined the list of countries that the supplement is now available in, which includes the United States, China and New Zealand. According to calocurb’s maker –... - May 31, 2019 - Calocurb
Pediatric Cancer Research Foundation to Host 26th Annual Western Roundup Event for Oncology Kids and Their Families
The Pediatric Cancer Research Foundation (PCRF) prepares to kick off the summer with its annual Western Roundup on Sunday, June 9th. - May 29, 2019 - Pediatric Cancer Research Foundation
Pillar Clinical Research Announces New Ratings Initiative: Pillar Precision
The Dallas based research company plans to roll out a new clinical rating training program, Pillar Precision. The program includes a clinician guide featuring best practices for specific CNS indications, placebo response training, malingering detection, data-driven decision making, and multi-site... - May 24, 2019 - Pillar Clinical Research
Apostle Inc. Completes Series A Financing Led by ShangBay Capital
Apostle Inc. is pleased to announce the completion of its series A financing, raising $3.3 million. The investment round is led by ShangBay Capital, a Silicon Valley-based venture capital firm, focused on investing in early stage medical device and biotech companies. Three other Silicon... - May 24, 2019 - Apostle Inc
First Responders Unite to Arrest and Extinguish ALS
Inaugural Arrest and Extinguish event at Tanglewood raises over $50,000 for ALS research. - May 23, 2019 - ALS Therapy Development Institute
ReproTech Nevada Participates in Fundraising Event to Support Women with Cancer
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), was proud to sponsor the entire staff of the ReproTech Nevada office who participated in Moms on the Run, a fitness organization that raises money to... - May 19, 2019 - ReproTech, LLC
First Responders Unite to End ALS at Inaugural Arrest & Extinguish Event
On May 18th, first responders will unite for a tug-of-war event at Tanglewood to raise money for ALS research. - May 11, 2019 - ALS Therapy Development Institute
Scientists at AbboMax Developed Antibodies Against PINK1 and Parkin to Study Parkinson’s Disease
A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be useful tools for studies of PINK/Parkin pathways and signaling in PD. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. AbboMax specializes in high-quality custom service and products focusing on antibody and assay development. - May 09, 2019 - AbboMax, Inc.
Reuters to Make Documentary on Paras Biopharmaceuticals Finland Oy – Innovations in Biologics: Insights of a Leading Expert
Paras Biopharmaceuticals Finland Oy is proud to announce that Reuters.com / Reuters Plus has selected the Finland-based company, working on biologics manufacturing & innovations in the healthcare segment as a valued contributor to the future of healthcare solutions. The documentary is part of... - May 07, 2019 - Paras Biopharmaceuticals Finland Oy
May is ALS Awareness Month - #AskMeAboutALS
May is ALS Awareness Month. The ALS Therapy Development Institute is inviting the general public to participate, and hoping to inspire a larger dialogue around ALS, through #AskMeAboutALS. - May 01, 2019 - ALS Therapy Development Institute
Texas Clinical Research Company Announces Expansion and New Quality Assurance Initiative
Pillar Clinical Research (Pillar), with a focus on early and late stage CNS drug development, opens two new US research facilities in Illinois and Arkansas and adds Director of Quality Assurance. Dr. Andrew Kim joined the Chicago team in September of 2018, and has spent over 5 years in clinical... - April 18, 2019 - Pillar Clinical Research
Zifo RnD Solutions Announces Launch of Sci-Desk
Zifo RnD Solutions announced the launch of its latest product Sci-Desk, an on-demand, cloud-based, Scientific Application Support-in-a-box. Sci-Desk offers comprehensive managed services for Scientific & lab computing systems spanning Discovery, R&D and Manufacturing industries. “Sci-Desk is a first of its kind in the Life Science R&D Spectrum. Sci-Desk brings on-demand, scalable, customizable and secure support to scientific applications,” said Raj Prakash, CEO/Co-Founder of Zifo RnD Solutions. - April 18, 2019 - Zifo
Mother’s Day Weekend Meso Run Becomes an Annual Event to Help Fight Mesothelioma
The second Annual Mother’s Day Weekend Meso Run/Walk 5K will be on May 11 in Griffith Park’s Old Zoo and aims to raise awareness of and funds for research on mesothelioma. - April 12, 2019 - Mother's Day Meso Run
NY Radiation Specialists Unveils State-of-the-Art Linear Accelerator at NYCBS
On Tuesday, March 25, New York Radiation Specialists unveiled its brand new Varian Halcyon Linear Accelerator, at New York Cancer & Blood Specialists’ Eastchester Center for Cancer Care. The “NYCBS” Eastchester location is a multi-lingual facility located at 2330 Eastchester... - April 08, 2019 - New York Radiation Specialists
Pediatric Cancer Research Foundation Receives Record Number of Scholarship Applications
Pediatric Cancer Research Foundation receives 100 applications from pediatric cancer survivors pursuing their education. - April 04, 2019 - Pediatric Cancer Research Foundation
NCHS Ramona Opens New Community Health Center
North County Health Services Opens New Health Clinic in Ramona. - April 02, 2019 - NCHS
Are Antioxidants the Solution to Burning and Itchy Eyes?
A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd
Huntington Study Group Achieves 100th Credentialed Research Site Milestone
The Huntington Study Group (HSG), a world leader in spearheading research and conducting clinical trials in Huntington disease (HD), is excited to announce that it has credentialed Inland Northwest Research, LLC as the 100th HSG site in North America. “On behalf of myself and our site, I... - March 25, 2019 - Huntington Study Group
Pediatric Cancer Research Foundation’s Reaching for the Cure Raises Over $430,000
The Pediatric Cancer Research Foundation celebrates another successful event. - March 25, 2019 - Pediatric Cancer Research Foundation
Ted Baker to Host Grand Opening Event Benefiting Pediatric Cancer Research Foundation
A portion of sales from an exclusive March 14th evening event will benefit Pediatric Cancer Research Foundation (PCRF), funding research to improve the care, quality of life, and survival rate of children battling cancer. - March 15, 2019 - Pediatric Cancer Research Foundation
Pediatric Cancer Research Foundation's Reaching for the Cure Half Marathon, 10K, 5K Kids Run Returns to Irvine on Sunday, March 17, 2019
Pediatric Cancer Research Foundation to host its annual fundraiser to benefit pediatric cancer research. - March 15, 2019 - Pediatric Cancer Research Foundation
New Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy
At just 2-1/4 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for optimizing space in critical microscopy and laboratory applications. - March 14, 2019 - Minus K Technology Inc.
ASAlaser's Results in 2018: An Exponential Growth in Turnover Since 2016
Significantly increased revenue from sales and performance compared with the past two years (+ 14.6% compared with 2017 and + 30% compared with 2016) for the company which focuses on laser therapy for both the Human and Veterinary sectors. The forecast target for 2019: a further increase in revenue from budgeted sales of 5.5% compared with the 2018 result. - March 14, 2019 - ASA srl
Scintica Instrumentation to Distribute the VelO2x Hypoxia Chamber System from Baker Ruskinn
Scintica Instrumentation Inc. is excited to announce its recent distribution agreement for the Baker Ruskinn preclinical VelO2x hypoxia chamber for scientific research. The VelO2x system has been engineered to provide an isolated and highly controlled oxygen environment to help researchers better understand how O2 levels affect various conditions such as sleep apnea, systemic hypertension, pulmonary dysfunction, ischemia and much more. - March 07, 2019 - Scintica Instrumentation
Apostle Inc. Enters Partnership with Beckman Coulter Life Sciences
Apostle Inc is pleased to announce an exclusive partnership with Beckman Coulter, a world leader in Life Sciences, for Apostle MiniMaxTMHigh Efficiency Cell-Free DNA Isolation Kit. As cell-free DNA (cfDNA) workflows move beyond theoretical and into human health applications, Apostle's industry... - February 28, 2019 - Apostle Inc
The Cardiac & Vascular Institute Officially Certified as Great Place to Work®
The Cardiac and Vascular Institute was certified as a great workplace by the independent analysts at Great Place to Work®. TCAVI earned this credential based on direct feedback from employees, provided as part of an extensive and anonymous survey about the workplace experience. A summary of... - February 26, 2019 - The Cardiac & Vascular Institute
Georgia Witkin, Ph.D. Appointed New Director of Psychological Services
Reproductive Medicine Associates of New York (RMA of New York), a global leader in state-of-the-art reproductive medicine, is pleased to announce the promotion of Georgia Witkin, Ph.D. to Director of Psychological and Wellness Services. Dr. Witkin has been practicing at RMA of New York since its... - February 20, 2019 - Reproductive Medicine Associates of New York
3D Preclinical Ultrasound Imaging System Launched in North America and Europe by Scintica Instrumentation
A 3D ultrasound imaging system for mice, rats and other small animals is now available to scientists throughout North America and Europe. The Prospect T1 is a cost effective, tablet based, high-frequency ultrasound imaging system, optimized to study hemodynamics and vascular function at the laboratory benchtop instead of from inside a core imaging facility. Scintica Instrumentation has the exclusive rights to sell and service the Prospect T1 with its team of scientific experts. - February 14, 2019 - Scintica Instrumentation Inc.
ALPCO Announces January 2019 Young Investigator Award Recipient of Its Diabetes Research Travel Grant
ALPCO awards its January 2019 Diabetes Research Travel Grant to Lisa Volpatti at Massachusetts Institute of Technology. - February 05, 2019 - ALPCO
Perthera, Inc. Announces the Appointment of Gary L. Gregory as Chief Executive Officer, President and Board Member
Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts. - February 04, 2019 - Perthera, Inc.
Red Pill Medical, Inc. Introduces New CBD Product Line to Combat the Common Problems Americans with an Active Lifestyle Face Everyday
Red Pill Medical's CEO Gregory A. Smith, M.D. (Producer of the American Addict films) has rolled out a new science-based line of CBD products designed for everyday use to address a variety of common complaints to help people reach their personal peak. - January 31, 2019 - Red Pill Medical, Inc.
Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology
Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology. Romiplostim has been produced with a proprietary and innovative continuous manufacturing... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy
The Pediatric Cancer Research Foundation Welcomes Two New Board Members in the Fight Against Pediatric Cancer
The Pediatric Cancer Research Foundation announces the addition of two new Board of Directors in 2019. - January 26, 2019 - Pediatric Cancer Research Foundation
Announcing Protectival - A Natural Way to Boost the Immune System and Enhance Cellular Health
After 15 year of research in collaboration with renowned Oncologists and Scientists, LifeBiotic is launching Protectival, a natural product boosting immunity and cellular health. - January 26, 2019 - Lifebiotic
The Pediatric Cancer Research Foundation Funds 9 New Research Grants in 2019
The Pediatric Cancer Research Foundation announces its new 2019 grantees in the fight against pediatric cancer. - January 17, 2019 - Pediatric Cancer Research Foundation
Bioquark Inc. and Ectocrine Technologies LLC to Collaborate on Mosquito-Derived Health Product Development
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.
ReproTech, Ltd. Awarded AATB Accreditations
ReproTech, Ltd.’s three facilities, in Minnesota, Florida and Nevada, have again been awarded the prestigious accreditation of the American Association of Tissue Banks (AATB), as well as its Texas facility receiving first-time AATB accreditation, it was announced in December, 2018 by Brent... - January 11, 2019 - ReproTech, LLC
The Cardiac & Vascular Institute and North Florida Regional Medical Center Join Together in a Clinical Trial to Test an Innovative Artificial Intelligence (AI) Device
The Cardiac & Vascular Institute (TCAVI) and North Florida Regional Medical Center (NFRMC) collaborated this week to test an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures. According to a press release, the AI device, (named... - January 09, 2019 - The Cardiac & Vascular Institute
Scintica Instrumentation to Distribute the Compact and Affordable MRI Preclinical System from Aspect Imaging
Scintica Instrumentation Inc. is excited to announce their distribution agreement in North America and Europe for Aspect Imaging’s preclinical M-Series™ Compact MRI system. The M-Series™ enable high-resolution 3D imaging without the need for special shielding, cryogens or water connections. Gold standard and affordable MR imaging can now be integrated into individual scientific laboratories, allowing researchers to harness the power and insights of MRI quickly and easily. - January 09, 2019 - Scintica Instrumentation Inc.
GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2
GeneFluidics is the only group selected for both NIAID antimicrobial resistance diagnostics projects (https://www.nih.gov/news-events/news-releases/nih-funds-nine-antimicrobial-resistance-diagnostics-projects) and as finalists for the NIH AMR Challenge Step 2 (https://dpcpsi.nih.gov/AMRChallenge/Finalists). - December 05, 2018 - GeneFluidics Inc.
Delk Enterprises, Inc. Acquires Interest in the International Peptide Society (IPS)
Venture capital firm announces transaction in online digital platform, investment to lead to strategic growth in the integrative medical space. - November 23, 2018 - International Peptide Society
New Horizons for Laser Therapy: ASAlaser Presents MiS – MLS® High Peak Pulse
The company from Vicenza, (Italy), a leader in the production of laser therapy, launches a new high-performing device at “Medica 2018” which offers early and scientifically proven results by combining the synchronised action of MLS® Laser Therapy with the pulse power of Hilterapia®. - November 20, 2018 - ASA srl
Wheeling Hospital First in U.S. to Use Surgical Device Tracking System
Wheeling Hospital has become the first U.S. medical facility to use the Matrix IT’s TRACTUS Scanner system to enhance the tracking of surgical implantable devices. Wheeling Hospital was selected to conduct trials of Matrix IT’s TRACTUS Scanner system. The surgical implantable devices... - November 15, 2018 - Matrix Medical Tracking Systems
Fertility Preservation Network Sponsors 2018 Cancer Fundraiser Event Teams
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was proud to sponsor local staff in multiple 2018 cancer research fundraisers. - November 09, 2018 - ReproTech, LLC
NCHS Celebrates Mission Mesa Women’s Health Ribbon-Cutting Ceremony
North County Health Services Reveals Recent Remodel. - November 01, 2018 - NCHS
ProPath to Participate in National Compliance and Ethics Week; Planned Events to Focus on the Importance of Acting Lawfully and Ethically
Corporate Compliance and Ethics Week, November 4-10, 2018 - November 01, 2018 - ProPath
ALPCO Launches FDA Class I Exempt STELLUX® Glucagon ELISA
ALPCO announces launch of its new highly specific FDA Class I Exempt STELLUX® Chemi Glucagon ELISA. - October 23, 2018 - ALPCO
Credo Biomedical to Present at Animal Health Innovation Summit
Credo Biomedical is one of the 12 finalists that have been selected to showcase during the Animal Health Innovation Summit in Hong Kong. - October 21, 2018 - Credo Biomedical Pte. Ltd.
Epitope Diagnostics, Inc. Certifies Its Total 25-OH Vitamin D EIA Kit Through the CDC’s Vitamin D Standardization-Certification Program (VDSCP)
Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI™ Total 25-OH Vitamin D EIA Kit. CDC’s Vitamin D Standardization-Certification Program (VDSCP) evaluates the... - October 21, 2018 - Epitope Diagnostics, Inc.